Post-treatment Assessment
On completing treatment, patients commenced surveillance imaging as per RMS2005 protocol[12] for recurrence and complications. In addition, a multidisciplinary clinic was established by the surgeons and oncologists to jointly review BP-RMS patients. A full history, examination and a systematic bladder function assessment were obtained for all, including frequency-volume-chart, voided volumes, post-void-residual (PVR) volume, flow studies, continence status and ultrasound scanning of the upper tracts and bladder. If a problem was identified, invasive video-urodynamics were performed. The expected bladder capacity for age (EBCA) was calculated based on the formula 30ml + (30ml times age in years) for children above 2 years of age[17] and 38ml + (2.5ml times age in months) for children less than 2 years[18]. Patients underwent serial bladder assessments as part of their follow-up. Variations in the documented functional capacity were oberved but only the most recent assessment reported.